Core Insights - NEXGEL, Inc. has appointed Joseph F. McGuire as Chief Financial Officer effective January 1, 2025, while the current CFO Adam E. Drapczuk III will transition to a consulting role [1][2] - The CEO, Adam Levy, emphasized the importance of acquiring experienced professionals to support the company's growth, highlighting McGuire's extensive background in public company finance [2] - McGuire brings over 30 years of experience in financial roles across various industries, including healthcare and financial services, and has previously guided a biotechnology company through its IPO [2][3] Company Overview - NEXGEL is a provider of healthcare, beauty, and over-the-counter products, specializing in ultra-gentle, high-water-content hydrogels [3] - The company has been developing and manufacturing electron-beam, cross-linked hydrogels for over two decades and has established brands such as SilverSeal and Hexagels [3] - NEXGEL maintains strategic contract manufacturing relationships with leading consumer healthcare companies [3]
NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer